Although serum alpha-fetoprotein (AFP) has been widely used as a biomarker for HCC screening, the sensitivity of AFP (58–68%) in detecting early-stage of HCC is still not satisfactory [3]. Here, AFP is linked to hepatocellular carcinoma.